Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.
about
Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acidsThe Role of microRNAs in the Diagnosis and Treatment of Pancreatic AdenocarcinomaCirculating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular CarcinomaRegulatory Roles of Non-Coding RNAs in Colorectal CancerCirculating RNAs as new biomarkers for detecting pancreatic cancerThe circulating transcriptome as a source of non-invasive cancer biomarkers: concepts and controversies of non-coding and coding RNA in body fluidsCell-free nucleic acids as noninvasive biomarkers for colorectal cancer detectionAn update on microRNAs as colorectal cancer biomarkers: where are we and what's next?Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia.Small RNA fragments derived from multiple RNA classes - the missing element of multi-omics characteristics of the hepatitis C virus cell culture modelMicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma.Translating RNA sequencing into clinical diagnostics: opportunities and challenges.DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.Alternative processing of the U2 small nuclear RNA produces a 19-22nt fragment with relevance for the detection of non-small cell lung cancer in human serum.Deep Sequencing of Serum Small RNAs Identifies Patterns of 5' tRNA Half and YRNA Fragment Expression Associated with Breast Cancer.Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer.Expression and clinical significance of microRNA-1246 in human oral squamous cell carcinomaApplication of high-throughput sequencing to circulating microRNAs reveals novel biomarkers for drug-induced liver injury.Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal CarcinomaPrimary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.MicroRNAs as Biomarkers in Cancer.Genome-Wide MicroRNA and Gene Analysis of Mesenchymal Stem Cell Chondrogenesis Identifies an Essential Role and Multiple Targets for miR-140-5p.Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for primary central nervous system lymphoma.Serum microRNA expression levels can predict lymph node metastasis in patients with early-stage cervical squamous cell carcinomaIsocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type.A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool.Ribonucleic artefacts: are some extracellular RNA discoveries driven by cell culture medium components?The non-coding transcriptome as a dynamic regulator of cancer metastasisNanoparticle-based detection of cancer-associated RNA.Biomarkers for early diagnosis of pancreatic cancer.The RNA world in the 21st century-a systems approach to finding non-coding keys to clinical questions.Current and future biomarkers for pancreatic adenocarcinoma.Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.Non-coding RNAs as Biomarkers for Colorectal Cancer Screening and Early Detection.MiR-1246 promotes SiHa cervical cancer cell proliferation, invasion, and migration through suppression of its target gene thrombospondin 2.Early detection of pancreatic cancer: Where are we now and where are we going?Analysis of U2 small nuclear RNA fragments in the bile differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders.Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis.MicroRNA-196a and -196b as Potential Biomarkers for the Early Detection of Familial Pancreatic Cancer.Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus.
P2860
Q26739062-6463FC74-405F-46B4-9372-485F0DAA6E00Q26744298-2C86A9DE-4311-4AF3-BE48-2BCDCB85EC56Q26767346-B03E439A-48F4-4EE7-B747-323546F6AF77Q26797350-643EE002-4C84-45C3-81B7-893923A94535Q26801191-829BFE08-1626-47AA-BB16-54D33B28DA3CQ26825022-ECCEEFFF-05B4-4D7D-BBF7-F782568C0302Q26991998-A88A3A01-7FC4-403D-922F-764F52B2D925Q27024427-00CC7167-0BDB-4C16-A384-21C94B3CD164Q33816293-1C83E44E-E98E-4E18-BE90-7CD0D43781B9Q33861677-33A58B82-9598-440B-88F2-87FDFD1A1863Q34116473-68B22683-7918-48D1-A2DF-29376189FAA7Q34519034-2B7B2ABA-CBBE-4DD0-BE5F-2EC0EFE25130Q34603514-0F7CAB7A-2018-4387-9509-513541AB3E9EQ34635648-9A484DC4-2418-455F-8977-FD1035CB4944Q34662408-5273FC42-1E42-403D-9049-69A8AEFE0FF8Q35148262-CD8F9B21-79AE-498F-BA26-74CD39F697ECQ35211914-F17687F2-262E-4A12-ACC7-F1DF6E9FCE95Q35379600-B977F8E1-9CF9-4EC7-9372-792D4430CB70Q35875417-9D236720-0D7A-4914-8CB1-4481B741C251Q36199767-F64AF778-06B4-4CB6-8E0F-2646179725C9Q36335261-82A27229-713D-438D-849C-2B8EF7CB75BDQ36532581-F44DD6CD-0684-4CFD-AE07-B4821CA66881Q36618225-F1483523-0DEA-4038-BD8D-728AE0C0E024Q37196131-B001541A-DD54-4CCE-B2C6-F96D41454C9AQ37358051-C7EE10AA-C4F6-44FA-BE63-18B8BD1717E5Q37641229-AB0C5C84-5402-4756-A402-1D4B77A9EBADQ37669563-7D885405-CDE5-4DD0-BAAB-F2D5B779FA06Q37705696-B1471F71-EA99-42D5-AF73-C96441BBCCC2Q38201412-989F3CBF-CD2F-49C6-8AA7-B4695C6DCAACQ38265405-1DA121C6-90EE-45CC-87FE-EBBF32F060DAQ38578754-D991C7EF-431C-4EE3-B455-1E31E6BA3751Q38670577-CD43B880-23AF-4080-B78B-DF31993103DDQ38929943-C479175E-B0A3-443C-8E9A-A5BB7EE89320Q38940607-964ED90A-3181-40FF-A315-D0BF04FC7808Q38997345-69C9466E-0E99-4114-AD97-2FE1275FAB7FQ39152619-4BE3FBBE-EE20-49E6-9ACF-E0BF31608B34Q39259431-9910461D-F8FB-47C8-9C03-3FA758343E95Q39389565-301D0F1B-D52F-4A0E-8D1F-A27797B86C19Q41769515-C57EA4DB-5ED7-4073-A8A7-97FF63428002Q42050374-489D35C7-E3C1-4B7B-8F1B-7497BB79EAF6
P2860
Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Circulating U2 small nuclear R ...... and colorectal adenocarcinoma.
@en
Circulating U2 small nuclear R ...... and colorectal adenocarcinoma.
@nl
type
label
Circulating U2 small nuclear R ...... and colorectal adenocarcinoma.
@en
Circulating U2 small nuclear R ...... and colorectal adenocarcinoma.
@nl
prefLabel
Circulating U2 small nuclear R ...... and colorectal adenocarcinoma.
@en
Circulating U2 small nuclear R ...... and colorectal adenocarcinoma.
@nl
P2093
P2860
P50
P921
P356
P1476
Circulating U2 small nuclear R ...... and colorectal adenocarcinoma.
@en
P2093
Abdelouahid Maghnouj
Alexander Baraniskin
Alexandra Wos
Andrea Tannapfel
Anke Reinacher-Schick
Ansgar M Chromik
Christian Stephan
Dennis Kost
Hannah Zöllner
Helmut E Meyer
P2860
P304
P356
10.1002/IJC.27791
P577
2012-09-14T00:00:00Z